{"id":11642,"date":"2026-02-23T07:01:54","date_gmt":"2026-02-23T07:01:54","guid":{"rendered":"https:\/\/www.musclestationth.com\/?p=11642"},"modified":"2026-02-25T08:52:17","modified_gmt":"2026-02-25T08:52:17","slug":"slu-pp-332","status":"publish","type":"post","link":"https:\/\/www.musclestationth.com\/en\/slu-pp-332\/","title":{"rendered":"What is SLU-PP-332? ERR targets and research limits"},"content":{"rendered":"<p>SLU-PP-332 is a small-molecule agonist of estrogen-related receptors, ERR alpha, beta and gamma, in research. It is not a peptide or the PPAR-delta agent described in the earlier incorrect text.<\/p><h2>What exercise mimetic means in this research<\/h2><p>It describes selected experimental responses compared with exercise. It does not establish replacement of exercise or performance enhancement in humans.<\/p><h2>What level of evidence is cited<\/h2><p>Billon and colleagues studied mouse models of obesity and metabolic syndrome. Mouse energy-metabolism findings are not clinical efficacy or safety evidence for an SA product in humans.<\/p><h2>SLU and SLP wording in the SA entry<\/h2><p>The SA legacy URL and artwork use SLP-PP-332, whereas the research uses SLU-PP-332. Label and identity evidence are needed to confirm equivalence. Earlier mention of Methylene Blue does not establish the formulation or combined effects.<\/p><h2>Frequently asked questions<\/h2><h3>Is SLU-PP-332 a peptide?<\/h3><p>No. It is a small molecule studied at ERR receptors.<\/p><h3>Are ERR and PPAR-delta the same target?<\/h3><p>No. The cited work concerns ERR; PPAR-delta information should not be substituted.<\/p><h3>Does this study establish human benefits?<\/h3><p>No. The cited study uses animal models.<\/p><h2>Read next<\/h2><p><a href=\"https:\/\/www.musclestationth.com\/en\/product\/sa-slp-pp-332\/\">SLU-PP-332 \/ SLP-PP-332 \u2014 SA Anabolic<\/a> \u00b7 <a href=\"https:\/\/www.musclestationth.com\/en\/mots-c\/\">What is MOTS-c? Mitochondrial peptide and evidence<\/a> \u00b7 <a href=\"https:\/\/www.musclestationth.com\/en\/aod-9604\/\">What is AOD-9604? HGH-related structure and weight evidence<\/a><\/p><h2>Sources<\/h2><ul><li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\/\">Billon et al., 2024 \u2014 Synthetic ERR agonist in mouse models<\/a><\/li><\/ul><p>Information checked 10 September 2026. Research and medicine labels above are separate from evidence for this listing image.<\/p><p>For general name or label questions, contact <a href=\"https:\/\/line.me\/R\/ti\/p\/@musclestationth\">LINE: @musclestationth<\/a><\/p><details class=\"msp-revision\"><summary>Revision note<\/summary><p>Earlier community-sourced use figures, performance promises and combination advice remain withdrawn.<\/p><\/details>","protected":false},"excerpt":{"rendered":"<p>SLU-PP-332 is a small-molecule agonist of estrogen-related receptors, ERR alpha, beta and gamma, in research. It is not a peptide or the PPAR-delta agent described in the earlier incorrect text.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"jetpack_seo_schema_type":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11642","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"admin","author_link":"https:\/\/www.musclestationth.com\/en\/author\/musclestationth\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.musclestationth.com\/en\/category\/uncategorized\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"SLU-PP-332 is studied as an ERR agonist, not the PPAR-delta activator previously described here. Human-use regimens and benefit predictions are withdrawn.","_links":{"self":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/11642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/comments?post=11642"}],"version-history":[{"count":3,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/11642\/revisions"}],"predecessor-version":[{"id":11661,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/posts\/11642\/revisions\/11661"}],"wp:attachment":[{"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/media?parent=11642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/categories?post=11642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.musclestationth.com\/en\/wp-json\/wp\/v2\/tags?post=11642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}